这项系统回顾和荟萃分析旨在确定甲状腺乳头状微小癌(PTMC)患者的复发率和死亡率是否比甲状腺叶切除术(TL)低。
使用PubMed,Cochrane库和EMBASE数据库,我们进行了一项荟萃分析,根据手术方式评估PTMC患者的临床结局.本荟萃分析计算相对危险度(RR)和95%置信区间(CI)。
共有11项队列研究,由13,801名患者组成,符合本系统评价和荟萃分析的纳入标准。总的来说,与TL组相比,TT组的复发率较低(RR=0.57,95%CI=0.35至0.94,P异质性=0.002,I2=65.2%),然而,两种手术方法的死亡率无显著差异(RR=0.84,95%CI=0.27~2.54,P异质性=0.023,I2=68.5%).对于基于国家和样本量的亚组分析,两组复发率无显著差异.
我们的荟萃分析表明,与甲状腺乳头状微小癌的甲状腺全切除术患者相比,接受甲状腺叶切除术的患者复发风险增加,但死亡风险不增加。
This systemic
review and meta-analysis was to determine whether the recurrence and mortality rates in papillary thyroid microcarcinoma (PTMC) patients were lower when treated with total thyroidectomy (TT) compared to thyroid lobectomy (TL).
Using PubMed, Cochrane library and EMBASE databases, we conducted a meta-analysis to assess the clinical outcomes in patients with PTMC based on surgical mode. The relative risk (RR) and 95% confidence interval (CI) were calculated for this meta-analysis.
A total of 11 cohort studies that comprised of 13,801 patients met the inclusion criteria for this systematic
review and meta-analysis. Overall, low recurrence rates were observed in the TT group compared to the TL group (RR = 0.57, 95% CI = 0.35 to 0.94, Pheterogeneity = 0.002, I2 = 65.2%), however, no significant differences were observed between the two surgical methods for mortality rates (RR = 0.84, 95% CI = 0.27 to 2.54, Pheterogeneity = 0.023, I2 = 68.5%). For subgroup analysis based on country and sample size, no significant differences were observed between the two groups for recurrence rates.
Our meta-analysis indicates that patients who underwent thyroid lobectomy had an increased risk of recurrence but not mortality compared to patients who had total thyroidectomy for papillary thyroid microcarcinoma.